Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dementia01:30

Dementia

482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Music as a scientific metaphor for mind and brain.

Neuroscience and biobehavioral reviews·2026
Same author

Correction: The role of brain health and resilience in reshaping trajectories of late-life neuropsychiatric disorders.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Evaluation of perception towards brain health in Nigeria: Results from a nationwide awareness survey.

Journal of public health in Africa·2026
Same author

Sociodemographic variables as predictors of antidepressant treatment outcome in major depressive disorder.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2026
Same author

Association of apolipoprotein E variants on Alzheimer's disease in Latin America: A systematic review and meta-analysis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Plasma ATN biomarkers across the alzheimer's disease continuum in a Chilean community- and clinic-based cohort.

Alzheimer's research & therapy·2026
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K

技术与痴呆症 会议前会议

Gustavo E Juantorena1,2, Waleska Berrios3,4,5, Maria Cecilia Fernández5

  • 1Instituo de Ciencias de la Computacion (CONICET-UBA), Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 23, 2025
PubMed
概括
此摘要是机器生成的。

这项研究使用了计算机化跟踪测试,包括眼睛和手部跟踪,以确定轻度认知障碍 (MCI) 的差异. 数字生物标志物揭示了MCI患者的明显运动模式,表明了改善的诊断潜力.

更多相关视频

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

相关实验视频

Last Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

科学领域:

  • 神经科学是一个神经科学.
  • 数字健康数字健康
  • 认知科学 认知科学

背景情况:

  • 轻度认知障碍 (MCI) 在使用传统的神经心理测试进行早期检测时存在挑战.
  • 计算机化评估为更敏感地检测认知缺陷提供了潜在的潜力.
  • 整合眼睛和手的跟踪提供细粒度的运动数据,用于增强分析.

研究的目的:

  • 与神经类型对照人群相比,研究MCI患者的细粒度运动和眼运动差异.
  • 探索计算机化Trail Making Test (c-TMT) 具有集成的眼睛和手部跟踪作为MCI的数字生物标志物的实用性.
  • 评估运动动态在识别微妙认知障碍方面的潜力.

主要方法:

  • 29名MCI患者和28名对照人完成了c-TMT,使用集成的眼睛 (500 Hz) 和小鼠跟踪.
  • 参与者在TMT-A和TMT-B试验之间交替进行,刺激呈现在屏幕上.
  • 线性混合模型 (LMM) 分析了性能指标 (完成率,试验时间) 和眼睛跟踪数据 (扫描路径长度,固定持续时间).

主要成果:

  • 在MCI患者和对照人群之间,在完成百分比和试验完成时间方面发现了显著的差异.
  • 扫描路径长度 (固定数) 根据试验类型和受试者组 (MCI与对照) 显示出显著差异.
  • 固定持续时间和眼手协调指标没有显示出显著的群体差异.

结论:

  • 开发的c-TMT有效地发现了MCI患者和对照人群之间扫描路径长度的显著差异.
  • 对手和眼睛运动的分析,特别是固定模式,可以揭示MCI的微妙变化.
  • 这种方法作为数字神经心理学的工具,有望为更精确的认知评估提供一个更有希望的方法.